NCT00346437View on ClinicalTrials.gov

Efficacy and Safety of Intracoronary Ad5FGF-4 in Patients With Stable Angina (AGENT-3)

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

416

Participants

Timeline

Start Date

October 31, 2001

Primary Completion Date

January 31, 2005

Study Completion Date

November 30, 2008

Conditions
Angina Pectoris
Interventions
GENETIC

Ad5FGF-4 vs. Placebo

Intracoronary infusion

Sponsors
All Listed Sponsors
lead

Cardium Therapeutics

INDUSTRY

NCT00346437 - Efficacy and Safety of Intracoronary Ad5FGF-4 in Patients With Stable Angina (AGENT-3) | Biotech Hunter | Biotech Hunter